Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Digit. Health

Sec. Connected Health

Volume 7 - 2025 | doi: 10.3389/fdgth.2025.1681221

This article is part of the Research TopicDigital Health Innovations for Patient-Centered CareView all 35 articles

Enhancing Neuropsychological Assessment Clinical Pathways in Parkinson's Disease Through the Use of Technology

Provisionally accepted
Elton  Henry Savio LoboElton Henry Savio Lobo1*Peter  WorthyPeter Worthy2Deborah  BrooksDeborah Brooks1Kirstine  ShrubsoleKirstine Shrubsole1Dana  PourzinalDana Pourzinal1Deepa  SriramDeepa Sriram1Rachel  FelsRachel Fels1Ji  Hyun YangJi Hyun Yang1Jacki  LiddleJacki Liddle1Leander  MitchellLeander Mitchell1Nadeeka  DissanayakaNadeeka Dissanayaka1
  • 1The University of Queensland Faculty of Health Medicine and Behavioural Sciences, Herston, Australia
  • 2School of Electrical Engineering and Computer Science, The University of Queensland, Brisbane, Australia

The final, formatted version of the article will be published soon.

Routine neuropsychological assessments for cognitive decline in Parkinson's disease (PD) face implementation barriers including lengthy administration, neuropsychologist shortages, and resource constraints. Understanding current practices remains crucial before introducing technological solutions. This preliminary PDCogniCare project study examined neuropsychological assessment practices for people with PD to identify technological integration opportunities. Fifteen clinical experts across two Australian public health services participated in semi-structured interviews. Data were analysed using inductive coding and journey mapping approaches. Analysis revealed a four-phase assessment journey: initiation, brief cognitive screening, detailed neuropsychological assessment, and feedback. Distinct pathway variations existed between services. Key challenges included extended waiting times, prolonged assessment duration, complex reporting requirements, and limited cognitive assessment awareness among patients and referring clinicians. While technology integration could begin to address some of these challenges through streamlined processes and improved access, barriers such as system integration, user adoption, and assessment methodology constraints require consideration. These findings reveal the complexity of neuropsychological assessment pathways and identified potential areas for technological enhancement. Future research from the PDCogniCare project will aim to address these areas by employing appropriate methodologies and theoretical models to guide the design and development of technologies for neuropsychological assessments in PD.

Keywords: Cognition, Journey map, neuropsychological assessment, Parkinson's disease, Technology

Received: 07 Aug 2025; Accepted: 24 Sep 2025.

Copyright: © 2025 Lobo, Worthy, Brooks, Shrubsole, Pourzinal, Sriram, Fels, Yang, Liddle, Mitchell and Dissanayaka. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Elton Henry Savio Lobo, elton.lobo@uq.edu.au

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.